Frontiers in Cell and Developmental Biology (Jul 2022)

Asymmetric Cell Division and Tumor Heterogeneity

  • Zizhu Li,
  • Zizhu Li,
  • Zizhu Li,
  • Ying Yi Zhang,
  • Haomiao Zhang,
  • Jiaxuan Yang,
  • Yongze Chen,
  • Hezhe Lu,
  • Hezhe Lu,
  • Hezhe Lu

DOI
https://doi.org/10.3389/fcell.2022.938685
Journal volume & issue
Vol. 10

Abstract

Read online

Asymmetric cell division (ACD) gives rise to two daughter cells with different fates after mitosis and is a fundamental process for generating cell diversity and for the maintenance of the stem cell population. The cancer stem cell (CSC) theory suggests that CSCs with dysregulated self-renewal and asymmetric cell division serve as a source of intra-tumoral heterogeneity. This heterogeneity complicates the diagnosis and treatment of cancer patients, because CSCs can give rise to aggressive clones that are metastatic and insensitive to multiple drugs, or to dormant tumor cells that are difficult to detect. Here, we review the regulatory mechanisms and biological significance of asymmetric division in tumor cells, with a focus on ACD-induced tumor heterogeneity in early tumorigenesis and cancer progression. We will also discuss how dissecting the relationship between ACD and cancer may help us find new approaches for combatting this heterogeneity.

Keywords